Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 12 | -179K | 100% | $94.97 | -$17M |
Net | -12 | -179K | -100% | -$17M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Jeffrey W. Albers | Director | $9.33M | -$5.7M | -37.9% | Jul 17, 2025 |
Nicholas Lydon | Director | $6.17M | Jun 12, 2024 | ||
Christopher K. Murray | Chief Technical Operations | $3.45M | Mar 7, 2024 | ||
Kate Haviland | Chief Executive Officer, Director | $2.54M | -$2.04M | -44.5% | Jul 17, 2025 |
Philina Lee | Chief Commercial Officer | $2.1M | -$331K | -13.6% | Jul 17, 2025 |
Christina Rossi | Chief Operating Officer | $952K | -$2.3M | -70.8% | Jul 17, 2025 |
Fouad Namouni | President, R & D | $952K | -$576K | -37.7% | Jul 17, 2025 |
George Demetri | Director | $837K | Jun 21, 2022 | ||
Debra Durso-Bumpus | Chief People Officer | $793K | -$458K | -36.6% | Jul 17, 2025 |
Percy H. Carter | Chief Scientific Officer | $793K | -$788K | -49.8% | Jul 17, 2025 |
Michael Landsittel | Chief Financial Officer | $793K | -$469K | -37.2% | Jul 17, 2025 |
Tracey L. McCain | EVP & Chief Legal Officer | $793K | -$467K | -37.1% | Jul 17, 2025 |
Ariel Hurley | Principal Accounting Officer | $670K | -$1.09M | -62% | Jul 17, 2025 |
Charles A. Rowland Jr | Director | $591K | Jun 2, 2021 | ||
Tango Therapeutics, Inc. | Director | $411K | Dec 8, 2021 | ||
L. Becker Hewes | Chief Medical Officer | $289K | -$891K | -75.5% | Jul 17, 2025 |
Lonnel Coats | Director | $47.9K | -$1.87M | -97.5% | Jul 17, 2025 |
Habib J. Dable | Director | $0 | Jul 17, 2025 | ||
Mark Alan Goldberg | Director | $0 | Jul 17, 2025 | ||
Daniella Beckman | Director | $0 | Jul 17, 2025 | ||
Alexis Borisy | Director | $0 | Jul 17, 2025 | ||
John Tsai | Director | $0 | Jul 17, 2025 | ||
Lynn Seely | Director | $0 | Jul 17, 2025 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|